CIR meets with Crawford

Cosmetic Ingredient Review provides FDA a list of 132 ingredients with insufficient safety data during its first meeting with FDA Acting Commissioner Lester Crawford, CIR Director Alan Andersen, PhD, reports during panel's June 13-14 meeting in Washington, D.C. Sitdown, which occurred April 25, is part of a new credibility action plan developed by the Cosmetic, Toiletry and Fragrance Association (1"The Rose Sheet" March 14, 2005, p. 3). CIR is seeking to encourage FDA to "implement its available regulatory authority to require warning labels or suggest to companies that warning labels may be required...as a way to encourage the industry to provide the data to fill the...gaps that the panel has identified," Anderson notes...